Literature DB >> 4982231

Immunochemical studies in four cases of alpha chain disease.

M Seligmann, E Mihaesco, D Hurez, C Mihaesco, J L Preud'homme, J C Rambaud.   

Abstract

Studies of a number of properties of the pathological gammaA-proteins in the first four cases of the recently recognized alpha-chain disease demonstrate that, as in gamma-heavy-chain disease, the abnormal protein is devoid of light chains and represents a portion of the alpha-heavy chain related to the Fc-fragment. In two patients, serum electrophoresis showed a broad abnormal band, whereas in the two others the pathological protein was not noticeable on the electrophoretic pattern. The diagnosis of alpha-chain disease can be established without purification of the protein by immuno-electrophoresis and gel diffusion experiments using selected antisera to gammaA and a reference alpha-chain disease protein. All four proteins belonged to the alpha1-subclass, displayed electrophoretic heterogeneity, and showed a strong tendency to polymerize. The polymers occurred in vivo and were held together both by disulfide bonds and by strong noncovalent forces. Two of the three purified proteins had a very high carbohydrate content. The abnormal protein was always found in concentrated urines in variable but generally low amounts. It was not detected in parotid saliva but was present in significant amounts in jejunal fluid of all four patients. The alpha-chain disease protein was shown to be associated with the secretory piece in external secretions of two patients. The clinicopathological features were strikingly similar in the four patients. All patients were affected with a neoplastic and mostly plasmacytic proliferation involving primarily the whole length of the small intestine and the mesenteric nodes and all exhibited a severe malabsorption syndrome. While Israeli authors have emphasized the frequency of this type of abdominal lymphoma in young Arabs and non-Ashkenazi Jews, two of our patients were Kabyles, one a Syrian Arab, and one an Eurasian. Cellular studies showed that the pathological protein was synthesized by the proliferating cells in the lymphoid tissue of the digestive tract and in the mesenteric nodes, and that there was no detectable light-chain synthesis at the intracellular level.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4982231      PMCID: PMC297495          DOI: 10.1172/JCI106204

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Subgroups of gamma-A immune globulins.

Authors:  H G Kunkel; R A Prendergast
Journal:  Proc Soc Exp Biol Med       Date:  1966-07

2.  [Immunohistochemical study of the plasmacytes of normal human intestinal mucosa].

Authors:  P A Crabbé; J F Heremans
Journal:  Rev Fr Etud Clin Biol       Date:  1966-05

3.  Antigenic determinants common to human immunoglobulins G and M: importance of conformational antigens.

Authors:  M Seligmann; C Mihaesco; G Meshaka
Journal:  Science       Date:  1966-11-11       Impact factor: 47.728

4.  A genetic predisposition to Waldenström's macroglobulinaemia.

Authors:  M Seligmann
Journal:  Acta Med Scand Suppl       Date:  1966

5.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

6.  Atypical antigenic properties of a gamma-A myeloma protein.

Authors:  C K Osterland; H Chaplin
Journal:  J Immunol       Date:  1966-05       Impact factor: 5.422

7.  Multiple myeloma involving the gastrointestinal tract.

Authors:  W B Goldstein; N Poker
Journal:  Gastroenterology       Date:  1966-07       Impact factor: 22.682

8.  Subclasses of human immunoglobulin a based on differences in the alpha polypeptide chains.

Authors:  J P Vaerman; J F Heremans
Journal:  Science       Date:  1966-08-05       Impact factor: 47.728

9.  Specificity of recombination of H and L chains from human gamma-G-myeloma proteins.

Authors:  H M Grey; M Mannik
Journal:  J Exp Med       Date:  1965-09-01       Impact factor: 14.307

10.  Recombination of heavy and light chains of human gamma-a-myeloma proteins: formation of hybrid molecules and configurational specificity.

Authors:  R A Prendergast; H M Grey; H G Kunkel
Journal:  J Exp Med       Date:  1966-08-01       Impact factor: 14.307

View more
  27 in total

1.  [Heavy chain disease: humoral and cellular findings in six patients with mu chain disease (author's transl)].

Authors:  O Wetter; C G Schmidt; K H Linder; W Leene
Journal:  J Cancer Res Clin Oncol       Date:  1979-06-08       Impact factor: 4.553

2.  Gamma heavy chain disease simulating alpha chain disease.

Authors:  S W Bender; F Danon; J L Preud'homme; H G Posselt; P Roettger; M Seligmann
Journal:  Gut       Date:  1978-12       Impact factor: 23.059

3.  IgA abnormalities in Mediterranean lymphoma (alpha chain disease).

Authors:  S N Salem; M W Kanan; B Lazarov; Y T Omar; H Al-Awady
Journal:  Postgrad Med J       Date:  1972-05       Impact factor: 2.401

4.  Primary upper small-intestinal lymphomal A report of 40 cases fron Iran.

Authors:  K Nasr; P Haghighi; K Bakhshandeh; P Abadi; A Lahimgarzadeh
Journal:  Am J Dig Dis       Date:  1976-04

5.  Molecular size heterogeneity of immunoglobulins in health and disease.

Authors:  P J Roberts-Thomson; K Shepherd
Journal:  Clin Exp Immunol       Date:  1990-03       Impact factor: 4.330

6.  Light chains in Mediterranean lymphoma.

Authors:  P G Isaacson; S K Price
Journal:  J Clin Pathol       Date:  1985-06       Impact factor: 3.411

7.  Alpha-chain disease in subSaharan Africa.

Authors:  B H Novis; L B Kahn; S Bank
Journal:  Am J Dig Dis       Date:  1973-08

8.  Binding of secretory piece to polymeric IgA and IgM paraproteins in vitro.

Authors:  J Rádl; F Klein; P van den Berg; A M de Bruyn; W Hijmans
Journal:  Immunology       Date:  1971-05       Impact factor: 7.397

9.  Alpha-chain disease with involvement of the respiratory tract in a Dutch child.

Authors:  J W Stoop; R E Ballieux; W Hijmans; B J Zegers
Journal:  Clin Exp Immunol       Date:  1971-11       Impact factor: 4.330

10.  Proteolytic degradation of exocrine and serum immunoglobulins.

Authors:  W R Brown; R W Newcomb; K Ishizaka
Journal:  J Clin Invest       Date:  1970-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.